CoChat

Effects of Simvastatin and omega‐3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia

Open access
Nordøy, Bønaa, Nilsen, Berge, Hansen, Ingebretsen · 1998 · Journal of Internal Medicine
Cited by 103

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Nordøy A, Bønaa KH, Nilsen H, Berge R, Hansen JB, Ingebretsen OC (University of Tromsø, Tromsø, Norway). Effects of Simvastatin and omega‐3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidemia. J Intern Med 1998; 243: 163–70. Objectives: .Patients with combined hyperlipidemia are at increased risk for development of coronary heart disease. The purpose of this study was to evaluate the efficiency and the safety of treatment with Simvastatin and omega‐3 fatty acids in patients with this lipid disorder. Design: .A double‐blind placebo controlled, randomized study evaluating the effects of Simvastatin separately and in combination with omega‐3 fatty acids in 41 healthy patients with defined hyperlipidemia. After a 16 weeks dietary run‐in period the patients were treated in periods of 5 weeks. Results: .As expected Simvastatin (20 mg day−1) reduced serum total cholesterol, triacylglycerols, apolipoproteins B and E and increased HDL‐cholesterol and apolipoprotein A 1. Addition of omega‐3 fatty acids (4 g day−1) further decreased serum triacylglycerols (P= 0.007), total cholesterol (P= 0.052) and apolipoprotein E (P= 0.035). No significant changes attributable to supplementation of polyunsaturated fatty acids on the content of lipid peroxides in plasma and in the various lipoprotein fractions were observed. Conclusions: .The combined treatment of Simvastatin and omega‐3 fatty acids seems to be an efficient and safe alternative for patients with combined hyperlipidemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2796.1998.00297.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 30

  1. The National Cholesterol Education Program (NCEP), 1993, Expert panel on Detection. Evaluation Treatment High Blood Cholesterol in Adults (summary)., JAMA, 269, 3015, 10.1001/jama.1993.03500230097036 · DOI · Paper page
  2. 10.1001/jama.269.4.505 · doi:10.1001/jama.269.4.505 · Paper page
  3. Musliner TA, 1988, Lipoprotein subspecies and risk of coronary disease., Clin LChem, 34, B78
  4. 10.2337/diab.37.12.1595 · DOI · Paper page
  5. 10.1056/NEJM199511163332001 · DOI · Paper page
  6. The Scandinavian Simvastatin Survival Group, 1994, Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. Scandinavian Simvastatin Survival Study. (45, Lancet, 344, 1383
  7. 10.1161/01.ATV.13.12.1755 · DOI · Paper page
  8. Reaven P, 1996, The role of dietary fat in LDL oxidation and atherosclerosis., Nutr Metab Cardiovasc Dis, 6, 57
  9. 10.3109/00365528109181959 · doi:10.3109/00365528109181959
  10. Burstein M, 1970, Rapid method for isolation of lipoproteins from human serum by precipitation with polyanions., J Lipid Res, 11, 583, 10.1016/S0022-2275(20)42943-8 · DOI · Paper page
  11. Strand H, 1997, Restriction fragment analysis by HPLC in apolipoprotein E genotyping. C, lin Chem, 43, 271
  12. 10.1016/0003-2697(75)90488-1 · DOI · Paper page
  13. Folch J, 1957, simple method for isolation and purification of total lipids from animal tissue., J Biol Chem, 226, 497, 10.1016/S0021-9258(18)64849-5 · DOI · Paper page
  14. Kaluzny MA, 1985, Rapid separation of lipid classes in high yield and purity using bonded phase columns., J Lipid Res, 26, 135, 10.1016/S0022-2275(20)34412-6 · DOI · Paper page
  15. Yagi K Assay for serum lipid peroxide level its clinical significance. In: Lipid Peroxides in Biology and Medicine. K. Yagi (ed.) New York. Academic Press 1982; 223–42. · DOI · Paper page
  16. 10.1016/0925-4439(94)90079-5 · doi:10.1016/0925-4439(94)90079-5
  17. El‐Saadani M, 1989, spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent., J Lipid Res, 30, 627, 10.1016/S0022-2275(20)38354-1 · DOI · Paper page
  18. 10.1016/S0021-9673(01)89358-4 · DOI
  19. Arnaud J, 1991, Simultaneous determination of retinol, α‐tocopherol and β‐carotene in serum by isocratic high‐performance liquid chromatography., J Chromatogr, 572, 103, 10.1016/0378-4347(91)80476-S · DOI · Paper page
  20. 10.1016/0009-8981(92)90029-P · doi:10.1016/0009-8981(92)90029-p
  21. 10.1016/0026-0495(95)90020-9 · DOI
  22. 10.1161/01.ATV.13.12.1790 · DOI
  23. 10.1093/ajcn/57.5.634 · DOI · Paper page
  24. 10.1097/00041433-199610000-00008 · DOI · Paper page
  25. 10.1172/JCI115499 · DOI · Paper page
  26. Nenseter MS, 1995, Dietary polyunsaturated and peroxidation of low density lipoprotein., Curr Opinon Lipid, 6, 167
  27. 10.1161/01.ATV.10.2.149 · DOI
  28. 10.1016/0002-9149(88)90004-5 · DOI · Paper page
  29. Pierce LR, 1990, Myopathy and rhabdomyolysis associated with lovastatin‐gemfibrozil combination therapy., JAMA, 264, 71, 10.1001/jama.1990.03450010075034 · DOI · Paper page
  30. 10.1161/01.ATV.13.1.98 · DOI

Cited by

See all 103

Metadata

Authors
Nordøy, Bønaa, Nilsen, Berge, Hansen, & Ingebretsen
Venue
Journal of Internal Medicine
Publisher
Wiley
Published
1998-02
Volume
243
Issue
2
Pages
163-170
ISSN
  • 0954-6820 (ISSN-L)
  • 1365-2796
OpenAlex
W2067335608
Cited by
103
References
3
FWCI
5.92
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Simvastatin and omega‐3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia. https://app.cochat.ai/papers/10.1046/j.1365-2796.1998.00297.x
The paper
Nordøy, Bønaa, Nilsen, Berge, Hansen, & Ingebretsen. (1998). Effects of Simvastatin and omega‐3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia. Journal of Internal Medicine. https://doi.org/10.1046/j.1365-2796.1998.00297.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.